| [1]Bradley EW, McGee-Lawrence ME, Westendorf JJ.Hdac-mediated control of endochondral and intramembranous ossification[J].Crit Rev Eukaryot Gene Expr,2011,21 (2):101-113.[2]McGee-Lawrence ME, Westendorf JJ.Histone deacetylases in skeletal development and bone mass maintenance[J].Gene,2011,474 (1-2):1-11.[3]Haberland M, Mokalled MH, Montgomery RL, et al.Epigenetic control of skull morphogenesis by histone deacetylase 8[J].Genes Dev,2009,23 (14):1625-1630.[4]Strahl BD, Allis CD.The language of covalent histone modifications[J].Nature,2000,403(6765):41-45.[5]Hassig CA, Schreiber SL.Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs[J].Curr Opin Chem Biol,1997,1(3):300-308.[6]Glozak MA, Sengupta N, Zhang X, et al.Acetylation and deacetylation of non-histone proteins[J].Gene,2005,363:15-23.[7]Choudhary C, Kumar C, Gnad F, et al..Lysine acetylation targets protein complexes and co-regulates major cellular functions[J].Science,2009,325(5942):834-840.[8]Jeon EJ, Lee KY, Choi NS, et al.Bone morphogenetic protein-2 stimulates Runx2 acetylation[J].J Biol Chem,2006,281 (24):16502-16511.[9]de Ruijter AJ, van Gennip AH, Caron HN, et al.Histone deacetylases (HDACs): characterization of the classical HDAC family[J].Biochem J,2003,370:737-749.[10]Blander G, Guarente L.The Sir2 family of protein deacetylases[J].Annu Rev Biochem,2004,73:417-435.[11]Oehme I, Deubzer HE, Wegener D, et al.Histone deacetylase 8 in neuroblastoma tumorigenesis[J].Clin Cancer Res,2009,15 (1):91-99.[12]Yan W,Liu S,Xu E,et al.Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8[J].Oncogene,2012,:-. |
